{
  "id": 1700,
  "text": "7 DFS: 88.7</td></tr><tr><td>Lorvidhaya et al.1267</td><td>2003</td><td>230</td><td>5 fluorouracil</td><td>nr</td><td>3-year 0S: 79 5-year 0s: 73.6 3-year PFS:63</td></tr></table></body></html> DFS disease-free survival, nr not reported, OS overall survival, PFS progression-free survival # 14 Distant metastatic disease at presentation & recurrent disease # 14.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 7 DFS: 88.7</td></tr><tr><td>Lorvidhaya et al.1267</td><td>2003</td><td>230</td><td>5 fluorouracil</td><td>nr</td><td>3-year 0S: 79 5-year 0s: 73.6 3-year PFS:63</td></tr></table></body></html> DFS disease-free survival, nr not reported, OS overall survival, PFS progression-free survival # 14 Distant metastatic disease at presentation & recurrent disease # 14.\n\n<question>: ",
  "ChatGPT_response_0": "根据临床研究结果显示的疾病无瘤生存率（DFS）为88.7％来看，这一结果可以说是相当可观的。然而，预期结果会因疾病种类、患者群体、治疗方案等因素而有所不同，因此是否符合预期可能取决于先前的研究、预期效果以及其他相关因素。总体而言，88.7％的DFS显示了一定的治疗有效性，但在评估效果时还应综合考虑其他因素以确保疗效与预期相符。",
  "query": "在此临床研究中，结果显示疾病无瘤生存率（DFS）为88.7％。这些结果是否符合您的预期？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在此临床研究中，结果显示疾病无瘤生存率（DFS）为88.7％。这些结果是否符合您的预期？\n\n<reference text>: 7 DFS: 88.7</td></tr><tr><td>Lorvidhaya et al.1267</td><td>2003</td><td>230</td><td>5 fluorouracil</td><td>nr</td><td>3-year 0S: 79 5-year 0s: 73.6 3-year PFS:63</td></tr></table></body></html> DFS disease-free survival, nr not reported, OS overall survival, PFS progression-free survival # 14 Distant metastatic disease at presentation & recurrent disease # 14.\n\n<reply>: ",
  "response": "根据临床研究结果显示的疾病无瘤生存率（DFS）为88.7％来看，这一结果可以说是相当可观的。然而，预期结果会因疾病种类、患者群体、治疗方案等因素而有所不同，因此是否符合预期可能取决于先前的研究、预期效果以及其他相关因素。总体而言，88.7％的DFS显示了一定的治疗有效性，但在评估效果时还应综合考虑其他因素以确保疗效与预期相符。"
}